Elizabeth McPhail
Chief Executive Officer
emcphail@kuitycorp.com
(888) 564-4060 x 110

Elizabeth has 15 years of executive level experience leading businesses. Currently, she is the CEO of KUITY Corp., an advanced analytics and software company that enables organizations to gain unprecedented competitive advantage, optimize performance and lower risk.

Most recently, Elizabeth has provided interim executive consulting services in the areas of general management, business development, product development and management, distribution and channel development, IP relationship development, company repositioning, board development, capital identification and mergers & acquisitions. Types of clients have encompassed: expert health system, medical device, MEMs energy, community health, technology service organization, medical group purchasing, science media, healthcare publishing, biopharmaceutical and pharmaceutical companies. Elizabeth has also become an investor in select circumstances.

From August 2000 through 2002, Elizabeth served as Sr. Vice President of New Business Strategies for Primary Provider Management Company, Inc. (“PPMC”), a healthcare holding company with core offerings including; PPO networks, professional management of specialist care outside of the hospital environment, and outsourced claims adjudication and management, to name a few. Within PPMC, Elizabeth created a publishing subsidiary, Rhyss Publishing, Inc. Rhyss publishes ZYSOURCE™--a comprehensive advertising-based decision support and informational resource delivered online and through a printed directory that identifies services and products in a format that enhances the purchasing process for physician offices, while providing vendors a cost-effective sales force extension vehicle for the multi-billion dollar medical office market. Elizabeth served as President of this subsidiary in addition to participating in the broader parent company executive leadership. Additionally, Elizabeth’s role included developing two previously acquired business units: 1) Benefit Management Systems, an 18 yr old ASP software solution company that provided outsourced healthcare adjudication and claims management services to the self-insured TPA marketplace, and 2) Behavior Research, a drug screening company offering services to government agencies, associations and large employers.

Previously, Elizabeth was a founding member, President and CEO of Medoris Holding Corp., a group purchasing cooperative developed to serve the physician market. She led this company from inception in 1995 through its acquisition in January 2000 to PrimeMed Pharmacy Services, Inc. PrimeMed (and Medoris) were subsequently sold to e-Medsoft.com, then a publicly traded company (AMEX: MED), in March of 2000. Following the sale, Elizabeth joined the PrimeMed and thereafter, the e-Medsoft.com executive leadership until her departure in August, 2000. In January of 2002, E-Medsoft.com changed its name as part of a structuring to Med Diversified.

As an overlapping commitment, commencing in 1997 and concluding in mid-1998, Elizabeth served as Interim President of First Opinion Corporation, a development-stage company with extensive intellectual property and expert system content for applied medical diagnostic applications. First Opinion was acquired in August 2007 by Healthways, Inc (HWAY: NASDAQ). She also founded an institutionally-oriented medical and pharmaceutical distribution company in 1992 that was sold in 1996.

Elizabeth received her Bachelor's degree in Organizational Leadership from The Pennsylvania State University.

Elizabeth currently sits on the Board of Directors of the Alliance Healthcare Foundation and Chairs their Finance Committee overseeing endowment investments totaling ~$90 million. She is also a member of the Board of Directors of 211 San Diego and Chairs the Audit and Business Development Committees. Additionally, she is Vice-Chair of the Board of Directors for Rhyss Publishing, and serves in an advisory and board capacity for a handful of early and development-stage companies.